BHVN

NYSE · Biotechnology

Biohaven Ltd

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.39

-0.35 (-4.00%)

As of Mar 24, 10:02 PM ET ·

Financial Highlights (FY 2025)

Revenue

166.56M

Net Income

26.40M

Gross Margin

61.2%

Profit Margin

15.9%

Rev Growth

+0.5%

D/E Ratio

0.62

Revenue & Net Income

Margin Trends

	FY 2025	FY 2024	FY 2023
Gross Margin	61.2%	61.2%	61.2%
Operating Margin	26.0%	25.4%	27.9%
Profit Margin	15.9%	17.2%	17.4%

Income Statement

	FY 2025	FY 2024	FY 2023
Revenue	166.56M	159.79M	165.80M
Gross Profit	101.91M	97.76M	101.44M
Operating Income	43.29M	40.63M	46.33M
Net Income	26.40M	27.52M	28.79M
Gross Margin	61.2%	61.2%	61.2%
Operating Margin	26.0%	25.4%	27.9%
Profit Margin	15.9%	17.2%	17.4%
Rev Growth	+0.5%	-2.4%	+23.6%

Balance Sheet

	FY 2025	FY 2024	FY 2023
Total Debt	483.78M	445.82M	505.70M
Total Equity	780.22M	946.94M	927.70M
D/E Ratio	0.62	0.47	0.55

Cash Flow

	FY 2025	FY 2024	FY 2023
EBITDA	53.49M	47.96M	56.14M
Free Cash Flow	17.32M	22.87M	17.57M